Success Metrics

Clinical Success Rate
94.4%

Based on 17 completed trials

Completion Rate
94%(17/18)
Active Trials
10(25%)
Results Posted
24%(4 trials)
Terminated
1(3%)

Phase Distribution

Ph phase_2
1
3%
Ph not_applicable
18
45%
Ph phase_1
1
3%
Ph phase_3
2
5%
Ph phase_4
3
8%
Ph early_phase_1
2
5%

Phase Distribution

3

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution27 total trials
Early Phase 1First-in-human
2(7.4%)
Phase 1Safety & dosage
1(3.7%)
Phase 2Efficacy & side effects
1(3.7%)
Phase 3Large-scale testing
2(7.4%)
Phase 4Post-market surveillance
3(11.1%)
N/ANon-phased studies
18(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.0%

17 of 21 finished

Non-Completion Rate

19.0%

4 ended early

Currently Active

10

trials recruiting

Total Trials

40

all time

Status Distribution
Active(12)
Completed(17)
Terminated(4)
Other(7)

Detailed Status

Completed17
Recruiting9
unknown6
Withdrawn3
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
40
Active
10
Success Rate
94.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (7.4%)
Phase 11 (3.7%)
Phase 21 (3.7%)
Phase 32 (7.4%)
Phase 43 (11.1%)
N/A18 (66.7%)

Trials by Status

completed1743%
active_not_recruiting13%
terminated13%
unknown615%
suspended13%
not_yet_recruiting13%
withdrawn38%
enrolling_by_invitation13%
recruiting923%

Recent Activity

10 active trials
Showing 5 of 40
recruiting

EEG Microstate Parameters and Neuroinflammatory Biomarkers in Patients With Treatment-Resistant Major Depressive Disorder Receiving ECT

NCT07748091
recruiting

EEG Microstate and Neuroinflammatory Biomarkers in Older Age Patients With Major Depressive Disorder Receiving ECT

NCT07740694
recruitingnot_applicable

Investigating Functional Changes in the Frontotemporal Cortex of Patients With Major Depressive Disorder Following Electroconvulsive Therapy or Magnetic Seizure Therapy Using Functional Near-infrared Spectroscopy (fNIRS)

NCT07533773
recruitingnot_applicable

Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy

NCT07473648
terminatednot_applicable

Maintenance TMS in Treatment Resistant Depression

NCT06682299
View all 40 trials

Clinical Trials (40)

Showing 20 of 40 trialsScroll for more
NCT07748091

EEG Microstate Parameters and Neuroinflammatory Biomarkers in Patients With Treatment-Resistant Major Depressive Disorder Receiving ECT

Recruiting
NCT07740694

EEG Microstate and Neuroinflammatory Biomarkers in Older Age Patients With Major Depressive Disorder Receiving ECT

Recruiting
NCT07533773Not Applicable

Investigating Functional Changes in the Frontotemporal Cortex of Patients With Major Depressive Disorder Following Electroconvulsive Therapy or Magnetic Seizure Therapy Using Functional Near-infrared Spectroscopy (fNIRS)

Recruiting
NCT07473648Not Applicable

Multimodal Clinical Study of Electroconvulsive Therapy and Magnetic Seizure Therapy

Recruiting
NCT06682299Not Applicable

Maintenance TMS in Treatment Resistant Depression

Terminated
NCT03191058Not Applicable

Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression

Completed
NCT07561307Not Applicable

Optimizing Stimulation Parameters for Electroconvulsive Therapy

Not Yet Recruiting
NCT05054699Phase 2

Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study

Active Not Recruiting
NCT07526454Not Applicable

Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder

Completed
NCT06733558Early Phase 1

Long-term Potentiation Disruption Underlying Cognitive Impairment in ECT

Withdrawn
NCT07324070Not Applicable

Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression

Recruiting
NCT05630469

Prediction of Antidepressant Effects of Electroconvulsive Therapy

Recruiting
NCT06355180Not Applicable

Esketamine vs ECT for Acute Suicidality

Completed
NCT05973643Not Applicable

Metabolomics During ElectroConvulsivoTherapy

Recruiting
NCT04057378Phase 4

Optimal Electrical Stimulus During Electroconvulsive Therapy

Recruiting
NCT04059952

Mechanism of Action of Electroconvulsive Therapy

Completed
NCT04160286

The Danish Neuropsychological Study of the Adverse Effects of ECT

Completed
NCT05515159

Blood Biomarkers in Electroconvulsive Therapy

Enrolling By Invitation
NCT04348825

Electroconvulsive Therapy and Neuroradiology

Completed
NCT05388461

Acute Efficacy and 6 Months Follow up After Electroconvulsive Therapy

Recruiting

Drug Details

Intervention Type
DEVICE
Total Trials
40